Skip to main content
2026 CRT Conference Main banner

CRT 2026

Innovation and Technology

Session:: HBD West 2026 | Positioning US-Japan Synergies for the Future [Non-CME]

Panel Discussion | How can we Promote Understanding and Awareness of the Global Regulatory and Clinical Landscape?

Sunday, March 8, 2026
12:00 PM - 12:35 PM EST

    Moderator(s)

  • Fumiaki Ikeno, MD

    Researcher
    Stanford University
    Stanford, California, United States

    Disclosure(s): No financial relationships to disclose

  • Mitchell Krucoff, MD, FACC, FAHA, FSCAI

    Professor Medicine/Cardiology
    Duke University Medical Center/Duke Clinical Research Institute
    Durham, North Carolina, United States

    Disclosure information not submitted.

  • KN

    Kiyohito Nakai

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Akihiro Ishiguro

    Head
    PMDA Washington D.C. Office
    Washington D.C., District of Columbia, United States

    Disclosure(s): No financial relationships to disclose

  • Margaret Kayo, PhD, MBA

    Regulatory Affairs
    HighLife / Margaret Inc
    St Augustine, Florida, United States

    Disclosure(s): No financial relationships to disclose

  • Aaron Lottes, PhD

    Assistant Dean of Engineering
    Purdue University
    WEST LAFAYETTE, Indiana, United States

    Disclosure(s): Merit Medical Systems Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Misti Malone, PhD

    Deputy Director, Office of Cardiovascular Devices
    FDA
    Silver Spring, Maryland, United States

    Disclosure information not submitted.

  • Kazuhisa Senshu, PhD

    Executive advisor
    Terumo Corporation
    Tokyo, Japan

    Disclosure(s): No financial relationships to disclose

  • RY

    Riku Yamamoto

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Fumiaki Ikeno, MD: No financial relationships to disclose
Akihiro Ishiguro: No financial relationships to disclose
Margaret Kayo, PhD, MBA: No financial relationships to disclose
Aaron Lottes, PhD: Merit Medical Systems Inc: Consulting Fees (e.g., advisory boards) (Ongoing)
Kazuhisa Senshu, PhD: No financial relationships to disclose
Riku Yamamoto: No financial relationships to disclose